Risedronic Acid
Back to searchMolecule Structure
Scientific Name
Risedronic Acid
Description of the Drug
Risedronic acid is a bisphosphonate used to treat osteoporosis and Paget’s disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00884
http://www.drugbank.ca/drugs/DB00884
Brand Name(s)
Not Available
Company Owner(s)
Allergan Pharmaceuticals International Ltd, Apotex Inc, Warner Chilcott Co Llc, Hangzhou Minsheng Binjiang Pharmaceutical Co Ltd, Impax Laboratories Inc, Macleods Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Orbion Pharmaceuticals Private Ltd, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Farnesyl diphosphate synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL1782 |
Clinical Trial(s)
Unichem Links
| Atlas | risedronate | |||||
| SureChEMBL | SCHEMBL18378 | |||||
| PharmGKB | PA451255 | |||||
| Human Metabolome Database | HMDB0015022 | |||||
| DrugBank | DB00884 | |||||
| PubChem: Thomson Pharma | 14799749 | |||||
| PubChem | 44400168 | 5245 | ||||
| Nikkaji | J476.065D | |||||
| PDBe | RIS | |||||
| BindingDB | 12576 | |||||
| EPA CompTox Dashboard | DTXSID2023563 | |||||
| DrugCentral | 2387 | |||||
| Brenda | 3722 | 252914 | 125151 | 42323 | 212816 | 88566 |
| ChemicalBook | CB1118762 | |||||
| Guide to Pharmacology | 3176 | |||||
| rxnorm | RISEDRONIC ACID | ACTONEL | RISEDRONATE SODIUM | RISEDRONATE | ||
| KEGG Ligand | C08233 | |||||
| ChEBI | 8869 | |||||
| ZINC | ZINC000001531009 |
